Masimo's Q4 sales jump 18%, but 2012 profits drop 2%

February 22, 2013 by Sony Salzman

Medical device company Masimo closes the year strong with an 18% bump in Q4 sales, but 2012 profits slip 2%.

Masimo (NSDQ:MASI) shares are down more than 1% since the medical device company reported its full-year and 4th-quarter results Feb. 14.

The Irvine, Calif.-based firm finished 2012 strong, reporting profits of $15.0 million, or 26¢ per share, on sales of $132.2 million for the 3 months ended Dec. 31, 2012. That represents an 18% sales bump from the same quarter last year.

For the full year, Masimo reported profits of $62.3 million, or $1.07 per share, on sales of $593.2 million, for a bottom-line slip of 2% compared with 2011.

Sign up to get our free newsletters delivered straight to your inbox

Adjusted to exclude 1-time items, Q4 earnings per share were 29¢ apiece, a penny ahead of Wall Street analysts' expectations. Full-year adjsuted EPS were $1.16, in line with expectations on The Street.

"We’ve entered 2013 fully focused on advancing our mission, strategy, and 2013 objectives, which is to continue to grow our core SET pulse oximetry business by increasing our presence in critical care and the general ward, while leveraging our breakthrough rainbow Pulse CO-oximetry platform to pursue new opportunities in and beyond the hospital setting," CEO Joe Kiani said in a company statement.

For 2013, Masimo said it expects revenues to reach $548 million.